These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12372239)

  • 21. Reappraisal of Contemporary Pharmacokinetic and Pharmacodynamic Principles for Informing Aminoglycoside Dosing.
    Bland CM; Pai MP; Lodise TP
    Pharmacotherapy; 2018 Dec; 38(12):1229-1238. PubMed ID: 30403305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics-pharmacodynamics of antimicrobial therapy: it's not just for mice anymore.
    Ambrose PG; Bhavnani SM; Rubino CM; Louie A; Gumbo T; Forrest A; Drusano GL
    Clin Infect Dis; 2007 Jan; 44(1):79-86. PubMed ID: 17143821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles.
    Hoo GSR; Liew YX; Kwa AL
    Indian J Med Microbiol; 2017; 35(3):340-346. PubMed ID: 29063877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basis of anti-infective therapy: pharmacokinetic-pharmacodynamic criteria and methodology for dual dosage individualisation.
    Sánchez-Navarro A; Sánchez Recio MM
    Clin Pharmacokinet; 1999 Oct; 37(4):289-304. PubMed ID: 10554046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial selection, administration and dosage.
    Baggot JD
    J S Afr Vet Assoc; 1998 Dec; 69(4):174-85. PubMed ID: 10192094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
    Peric M; Browne FA; Jacobs MR; Appelbaum PC
    Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimicrobial pharmacodynamics.
    Ambrose PG; Owens RC; Grasela D
    Med Clin North Am; 2000 Nov; 84(6):1431-46. PubMed ID: 11155851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of antiinfective therapy: taking what we know to the patient's bedside.
    Rodvold KA
    Pharmacotherapy; 2001 Nov; 21(11 Pt 2):319S-330S. PubMed ID: 11714223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of respiratory tract infections.
    Andes D; Anon J; Jacobs MR; Craig WA
    Clin Lab Med; 2004 Jun; 24(2):477-502. PubMed ID: 15177850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection.
    Bradley JS; Garonzik SM; Forrest A; Bhavnani SM
    Pediatr Infect Dis J; 2010 Nov; 29(11):1043-6. PubMed ID: 20975453
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics and the dosage regimen of antimicrobial agents.
    Powers TE; Powers JD
    Ann Rech Vet; 1990; 21 Suppl 1():41S-45S. PubMed ID: 2080846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Animal models in the pharmacokinetic/pharmacodynamic evaluation of antimicrobial agents.
    Zhao M; Lepak AJ; Andes DR
    Bioorg Med Chem; 2016 Dec; 24(24):6390-6400. PubMed ID: 27887963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach.
    Mouton JW; Brown DF; Apfalter P; Cantón R; Giske CG; Ivanova M; MacGowan AP; Rodloff A; Soussy CJ; Steinbakk M; Kahlmeter G
    Clin Microbiol Infect; 2012 Mar; 18(3):E37-45. PubMed ID: 22264314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome.
    Sádaba B; Azanza JR; Campanero MA; García-Quetglas E
    Clin Microbiol Infect; 2004 Nov; 10(11):990-8. PubMed ID: 15522002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Setting and revising antibacterial susceptibility breakpoints.
    Turnidge J; Paterson DL
    Clin Microbiol Rev; 2007 Jul; 20(3):391-408, table of contents. PubMed ID: 17630331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients.
    Smith PF; Ballow CH; Booker BM; Forrest A; Schentag JJ
    Clin Ther; 2001 Aug; 23(8):1231-44. PubMed ID: 11558860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interpretive reading of the antibiogram: a clinical necessity].
    Cantón R
    Enferm Infecc Microbiol Clin; 2010; 28(6):375-85. PubMed ID: 20381926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous Antibiotic and Antifungal Agent Pharmacokinetic-Pharmacodynamic Dosing in Adults with Severe Burn Injury.
    Cota JM; FakhriRavari A; Rowan MP; Chung KK; Murray CK; Akers KS
    Clin Ther; 2016 Sep; 38(9):2016-31. PubMed ID: 27586127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological indices in antibiotic therapy.
    Barger A; Fuhst C; Wiedemann B
    J Antimicrob Chemother; 2003 Dec; 52(6):893-8. PubMed ID: 14613960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacodynamics of antimicrobial agents. Bactericidal and postantibiotic effects.
    Levison ME
    Infect Dis Clin North Am; 1995 Sep; 9(3):483-95. PubMed ID: 7490429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.